文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

持续性而非一过性急性肾损伤与急性肝衰竭患者无移植生存率降低相关:一项多中心队列研究

Persistent But Not Transient Acute Kidney Injury Was Associated With Lower Transplant-Free Survival in Patients With Acute Liver Failure: A Multicenter Cohort Study.
PubMed 文献 · Crit Care Med · 2022-04-21
一句话结论急性肝衰竭患者中持续性急性肾损伤(AKI)与21天无移植生存率降低独立相关,一过性AKI则无此关联。

该国际多中心回顾性队列基于美国ALF研究组前瞻性登记库1998至2016年数据,纳入1071例成人急性肝衰竭患者。第1天按KDIGO标准定义AKI,第3天定义一过性AKI(48小时内恢复至无AKI)和持续性AKI(未恢复或需肾脏替代治疗)。第1天62.8%存在AKI,第3天6.7%为一过性AKI、56.1%为持续性AKI、6.6%为晚发AKI、30.5%无AKI。校正混杂因素后,持续性AKI(aOR 0.62,95%CI 0.44-0.88)和晚发AKI(aOR 0.48,95%CI 0.26-0.89)与21天无移植生存率降低相关,一过性AKI则无显著关联(aOR 1.89,95%CI 0.99-3.64)。

要点

  • 在1071例成人急性肝衰竭患者中,第1天62.8%存在AKI,第3天持续性AKI占56.1%,一过性AKI仅占6.7%。
  • 校正年龄、性别、种族、病因、肝性脑病分级、有创机械通气、血管加压药、INR和年份后,持续性AKI与21天无移植生存率降低独立相关(aOR 0.62,95%CI 0.44-0.88)。
  • 晚发AKI同样与21天无移植生存率降低相关(aOR 0.48,95%CI 0.26-0.89)。
  • 一过性AKI与21天无移植生存率无显著关联(aOR 1.89,95%CI 0.99-3.64)。
  • 第1天45.3%为3-4级肝性脑病,46.7%需有创机械通气,18.4%使用血管加压药,20.6%接受肾脏替代治疗。

适用人群与场景

  • 年龄大于等于18岁、登记于美国ALF研究组前瞻性登记库(1998至2016年)的急性肝衰竭患者。
  • 排除随访不足3天、第3天无肾功能评估或合并肝硬化的患者。

诊断标准与关键阈值

  • AKI定义:第1天按肾脏疾病改善全球预后(KDIGO)指南标准。
  • 一过性AKI:第3天评估时,48小时内恢复至无AKI。
  • 持续性AKI:第3天评估时未恢复至无AKI,或观察到需要肾脏替代治疗(RRT)。
  • 晚发AKI:第3天评估时新出现的AKI。

研究设计与关键结果

  • 研究类型:国际多中心回顾性队列,基于美国ALF研究组前瞻性登记库,纳入1071例成人急性肝衰竭患者。
  • 人群特征:男性339例(31.7%),中位年龄39岁(四分位距29-51岁),对乙酰氨基酚相关ALF 497例(46.4%)。
  • 第1天病情:3-4级肝性脑病485/1071例(45.3%),有创机械通气500/1070例(46.7%),使用血管加压药197/1070例(18.4%),接受RRT 221/1071例(20.6%)。
  • AKI分布:第1天AKI 673/1071例(62.8%);第3天持续性AKI 601/1071例(56.1%),一过性AKI 72/1071例(6.7%),晚发AKI 71/1071例(6.6%),无AKI 327/1071例(30.5%)。
  • 主要终点:校正年龄、性别、种族、病因、肝性脑病分级、有创机械通气、血管加压药、INR和年份后,持续性AKI与21天无移植生存率降低相关(aOR 0.62,95%CI 0.44-0.88),晚发AKI同样相关(aOR 0.48,95%CI 0.26-0.89),一过性AKI无显著关联(aOR 1.89,95%CI 0.99-3.64)。

证据类型、等级与局限

  • 证据类型:国际多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在急性肝衰竭患者中,持续性而非一过性AKI与较低的短期无移植生存率独立相关,提示临床关注AKI的持续时间有助于风险分层。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Acute liver failure (ALF) is an orphan disease often complicated by acute kidney injury (AKI). We assessed the impact of transient versus persistent AKI on survival in patients with ALF.

DESIGN: International multicenter retrospective cohort.

SETTING: U.S. ALF Study Group prospective registry.

PATIENTS: Patients with greater than or equal to 18 years and ALF in the registry from 1998 to 2016 were included. Patients with less than 3 days of follow-up, without kidney function evaluation on day 3, or with cirrhosis were excluded.

INTERVENTIONS: AKI was defined by Kidney Disease Improving Global Outcomes guidelines on day 1. Kidney recovery was defined on day 3 as transient AKI, by a return to no-AKI within 48 hours or persistent AKI if no such recovery or renal replacement therapy (RRT) was observed. Primary outcome was transplant-free survival (TFS) at 21 days.

MEASUREMENTS AND MAIN RESULTS: Among 1,071 patients with ALF, 339 (31.7%) were males, and median (interquartile range) age was 39 years (29-51 yr). Acetaminophen-related ALF was found in 497 patients (46.4%). On day 1, 485 of 1,071 patients (45.3%) had grade 3-4 hepatic encephalopathy (HE), 500 of 1,070 (46.7%) required invasive mechanical ventilation (IMV), 197 of 1,070 (18.4%) were on vasopressors, and 221 of 1,071 (20.6%) received RRT. On day 1, 673 of 1,071 patients (62.8%) had AKI. On day 3, 72 of 1,071 patients (6.7%) had transient AKI, 601 of 1,071 (56.1%) had persistent AKI, 71 of 1,071 (6.6%) had late onset AKI, and 327 of 1,071 (30.5%) remained without AKI. Following adjustment for confounders (age, sex, race, etiology, HE grade, use of IMV and vasopressors, international normalized ratio, and year), although persistent acute kidney injury (adjusted odds ratio [aOR] [95% CI] 0.62 [0.44-0.88]) or late onset AKI (aOR [95% CI] 0.48 [0.26-0.89]) was associated with lower TFS, transient AKI was not (aOR [95% CI] 1.89 [0.99-3.64]).

CONCLUSIONS: In a multicenter cohort of patients with ALF, persistent but not transient AKI was independently associated with lower short-term TFS.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Cardoso FS, Fidalgo P, Bagshaw SM, et al. Persistent But Not Transient Acute Kidney Injury Was Associated With Lower Transplant-Free Survival in Patients With Acute Liver Failure: A Multicenter Cohort Study. Crit Care Med. 2022. PMID: 35446272. doi:10.1097/CCM.0000000000005563

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。